【レポートの概要（一部）】
TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 MARKET SCOPE 29
1.3.1 MARKETS COVERED 29
1.3.2 YEARS CONSIDERED FOR THE STUDY 29
1.4 CURRENCY 30
1.5 LIMITATIONS 30
1.6 STAKEHOLDERS 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
2.1.1 SECONDARY DATA 33
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 34
2.1.2.1 Key data from primary sources 35
2.1.2.2 Key industry insights 36
2.2 MARKET SIZE ESTIMATION 36
2.2.1 MARKET DATA VALIDATION AND TRIANGULATION 38
2.3 ASSUMPTIONS FOR THE STUDY 39
3 EXECUTIVE SUMMARY 40
4 PREMIUM INSIGHTS 44
4.1 DRUG DELIVERY TECHNOLOGY: MARKET OVERVIEW 44
4.2 DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION,
2018 VS. 2023 (USD BILLION) 45
4.3 DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE,
2018–2023 (USD BILLION) 45
4.4 DRUG DELIVERY TECHNOLOGY MARKET SHARE, BY APPLICATION AND REGION, 2018 46
4.5 DRUG DELIVERY TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 48
5.3 DRIVERS 49
5.3.1 RISING PREVALENCE OF CHRONIC DISEASES 49
5.3.2 GROWTH IN THE BIOLOGICS MARKET 50
5.3.3 TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES 50
5.4 RESTRAINTS 51
5.4.1 RISK OF NEEDLESTICK INJURIES 51
5.5 OPPORTUNITIES 51
5.5.1 SELF-ADMINISTRATION AND HOME CARE 51
5.5.2 RISING DEMAND FOR BIOSIMILARS 52
5.6 CHALLENGES 52
5.6.1 PRICING PRESSURE 52
6 DRUG DELIVERY TECHNOLOGY MARKET, BY ROUTE OF ADMINISTRATION 53
6.1 INTRODUCTION 54
6.2 ORAL DRUG DELIVERY 55
6.2.1 SOLID ORAL DRUGS 57
6.2.1.1 Tablets 58
6.2.1.1.1 Development of mini-tablets is a key trend in this market segment. 58
6.2.1.2 Capsules 58
6.2.1.2.1 Easy absorption of drugs and decreased irritation in the GI tract are driving the use of capsules 58
6.2.1.3 Powders 59
6.2.1.3.1 Powders are taken by patients who are unable to swallow oral dosage forms 59
6.2.1.4 Pills 60
6.2.1.4.1 Rising incidence of target ailments will propel the growth of the pills market 60
6.2.2 LIQUID ORAL DRUGS 61
6.2.2.1 Syrups 62
6.2.2.1.1 Liquid syrups can be easily administered to patients with swallowing difficulties 62
6.2.2.2 Solutions 63
6.2.2.2.1 Solutions are generally preferred by geriatric and pediatric patients 63
6.2.3 SEMI-SOLID ORAL DRUGS 64
6.2.3.1 Gels 65
6.2.3.1.1 Gels are used for controlled drug release 65
6.2.3.2 Emulsions 65
6.2.3.2.1 Microemulsions offer protection against oxidation and enzymatic hydrolysis 65
6.2.3.3 Elixirs 66
6.2.3.3.1 Elixirs are hydraulic in nature and contain sweet and flavored substances 66
6.3 INJECTABLE DRUG DELIVERY 67
6.3.1 CONVENTIONAL INJECTION DEVICES 68
6.3.1.1 By material 69
6.3.1.1.1 Glass 70
6.3.1.1.1.1 Glass syringes are considered to be one of the most durable and safe materials to store biologic drugs 70
6.3.1.1.2 Plastic 71
6.3.1.1.2.1 Plastic syringes are reasonably priced as compared to their glass counterparts 71
6.3.1.2 By product 72
6.3.1.2.1 Fillable syringes 72
6.3.1.2.1.1 Ease of use and variable dosing formulations of fillable syringes are the major factors driving market growth 72
6.3.1.2.2 Prefilled syringes 73
6.3.1.2.2.1 Prefilled syringes offer improved dose accuracy and increased patient convenience and safety 73
6.3.1.3 By usability 74
6.3.1.3.1 Reusable syringes 74
6.3.1.3.1.1 Reusable syringes are easy to dismantle and clean 74
6.3.1.3.2 Disposable syringes 75
6.3.1.3.2.1 Disposable syringes are widely used in medical practices due to their low cost and convenience 75
6.3.2 SELF-INJECTION DEVICES 76
6.3.2.1 Needle-free injectors 77
6.3.2.1.1 Needle-free injectors enable fast drug delivery and show better reproducibility as compared to invasive drug delivery systems 77
6.3.2.2 Autoinjectors 78
6.3.2.2.1 Autoinjectors provide improved patient satisfaction as compared to manual injections 78
6.3.2.3 Pen injectors 78
6.3.2.3.1 Pen injectors are generally used when medications have to be administered more than once a week 78
6.3.2.4 Wearable injectors 79
6.3.2.4.1 Increasing adoption of home infusion therapy and rising focus on cost-curtailment in healthcare are supporting market growth 79
6.3.3 OTHER INJECTOR DEVICES 80
6.4 TOPICAL DRUG DELIVERY 80
6.4.1 LIQUID FORMULATIONS 82
6.4.1.1 Solutions 83
6.4.1.1.1 Solutions accounted for a larger share of the topical drug delivery technology market for liquid formulations in 2018 83
6.4.1.2 Suspensions 83
6.4.1.2.1 Factors such as higher rate of bioavailability and controlled onset of action to support the growth of the topical suspensions market in the coming years 83
6.4.2 SEMI-SOLID FORMULATIONS 84
6.4.2.1 Creams 85
6.4.2.1.1 Creams are either water-in-oil or oil-in-water emulsions 85
6.4.2.2 Gels 86
6.4.2.2.1 Factors such as faster drug release and greater patient acceptability to drive the market for topical gels 86
6.4.2.3 Ointments 86
6.4.2.3.1 Ointments are widely used in analgesic indications 86
6.4.2.4 Pastes 87
6.4.2.4.1 Topical pastes are widely used for the treatment and prevention of skin irritation 87
6.4.2.5 Lotions 88
6.4.2.5.1 Easy administration of lotions to drive their demand among end users 88
6.4.3 SOLID FORMULATIONS 88
6.4.3.1 Suppositories 89
6.4.3.1.1 Suppositories require a suitable base that ensures the compatibility and stability of the drug 89
6.4.3.2 Powders 90
6.4.3.2.1 Powders have a very fine particle size that covers a large surface area per unit weight 90
6.4.4 TRANSDERMAL PRODUCTS 90
6.4.4.1 Transdermal patches 91
6.4.4.1.1 Transdermal patches prevent the premature metabolization of the drug through the liver 91
6.4.4.2 Transdermal gels 92
6.4.4.2.1 Transdermal gels help in the faster release of drugs on the target site 92
6.5 OCULAR DRUG DELIVERY 93
6.5.1 LIQUID FORMULATIONS 95
6.5.1.1 Eye drops 96
6.5.1.1.1 Rising prevalence of cataracts and other eye diseases is driving market growth 96
6.5.1.2 Liquid sprays 97
6.5.1.2.1 Liquid sprays have helped in overcoming drawbacks associated with traditional eye drops 97
6.5.2 SEMI-SOLID FORMULATIONS 97
6.5.2.1 Gels 98
6.5.2.1.1 High viscosity of drugs, prolonged drug release, and ease of drug administration are factors contributing to market growth 98
6.5.2.2 Eye ointments 99
6.5.2.2.1 Eye ointments are safe to use, and help in improving ocular contact time with the drug 99
6.5.3 OCULAR DEVICES 99
6.5.3.1 Drug-coated contact lenses 100
6.5.3.1.1 Better eyesight offered by lenses & high compliance to drive the market for drug-coated contact lenses 100
6.5.3.2 Ocular inserts 101
6.5.3.2.1 Ocular inserts help in the sustained release of drugs in the eye 101
6.6 PULMONARY DRUG DELIVERY 102
6.6.1 METERED-DOSE INHALERS 103
6.6.1.1 These inhalers overcome the problem of poor coordination between inhaler actuation and patient breath 103
6.6.2 DRY POWDER INHALERS 104
6.6.2.1 DPI drug formulations are chemically more stable than their counterparts are 104
6.6.3 NEBULIZERS 105
6.6.3.1 Jet nebulizers 106
6.6.3.1.1 Jet nebulizers account for the largest share of the nebulizers market 106
6.6.3.2 Ultrasonic nebulizers 107
6.6.3.2.1 Ultrasonic nebulizers are easy to use and comfortable to handle 107
6.6.3.3 Soft mist nebulizers 108
6.6.3.3.1 Soft Mist nebulizers are preferred for the treatment of severe COPD 108
6.7 NASAL DRUG DELIVERY 108
6.7.1 NASAL DROPS 110
6.7.1.1 Nasal drops are considered more efficient than nasal sprays 110
6.7.2 NASAL SPRAYS 110
6.7.2.1 Nasal sprays help in relieving nasal congestion, runny nose, itchy nose, and sneezing 110
6.7.3 NASAL POWDERS 111
6.7.3.1 Absence of preservatives & superior stability of formulations are some of the advantages associated with nasal powders 111
6.7.4 NASAL GELS 112
6.7.4.1 Nasal gels provide long-lasting relief from dry nasal passages and also reduce irritation caused by using soothing excipients 112
6.8 TRANSMUCOSAL DRUG DELIVERY 112
6.8.1 ORAL FORMULATIONS 114
6.8.1.1 Buccal drug delivery 115
6.8.1.1.1 Buccal drug delivery system is suitable for local and systematic therapies 115
6.8.1.2 Sublingual drug delivery 116
6.8.1.2.1 The rate of drug absorption through the sublingual route is 3–10 times higher than the oral route 116
6.8.2 OTHER TRANSMUCOSAL DRUG DELIVERY TECHNOLOGIES 117
6.8.2.1 Rectal transmucosal drug delivery 118
6.8.2.1.1 The rectal route of drug delivery rapidly absorbs drugs that are aqueous in nature 118
6.8.2.2 Vaginal transmucosal drug delivery 118
6.8.2.2.1 The permeability of the drug is high through the vaginal route of administration 118
6.9 IMPLANTABLE DRUG DELIVERY 119
6.9.1 ACTIVE IMPLANTABLE DRUG DELIVERY 121
6.9.1.1 Active implantable devices are used for diagnostic monitoring, body fluids transportation, and ionized radiation 121
6.9.2 PASSIVE IMPLANTABLE DRUG DELIVERY 122
6.9.2.1 Passive implants primarily include joint replacements, heart valves, aneurysm clips, coronary stents, and breast implants 122
7 DRUG DELIVERY TECHNOLOGY MARKET, BY FACILITY OF USE 123
7.1 INTRODUCTION 124
7.2 HOSPITALS 125
7.2.1 HOSPITALS WILL CONTINUE TO DOMINATE THE DRUG DELIVERY TECHNOLOGY MARKET DURING THE FORECAST PERIOD 125
7.3 AMBULATORY SURGERY CENTERS/CLINICS 125
7.3.1 INCREASING PREFERENCE FOR ASCS HAS RESULTED IN A SIGNIFICANT RISE IN DEMAND FOR DRUG DELIVERY TECHNOLOGIES 125
7.4 HOME CARE SETTINGS 126
7.4.1 HOME CARE SETTINGS TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 126
7.5 DIAGNOSTIC CENTERS 127
7.5.1 RISING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 127
7.6 OTHER FACILITIES OF USE 128
8 DRUG DELIVERY TECHNOLOGY MARKET, BY APPLICATION 129
8.1 INTRODUCTION 130
8.2 INFECTIOUS DISEASES 131
8.2.1 HIGH BURDEN OF INFECTIOUS DISEASES ACROSS THE GLOBE TO DRIVE MARKET GROWTH 131
8.3 CANCER 132
8.3.1 CANCER FORMS A KEY THERAPEUTIC APPLICATION SEGMENT FOR DRUG DELIVERY TECHNOLOGIES 132
8.4 CARDIOVASCULAR DISEASES 133
8.4.1 INCREASING PREVALENCE OF CVDS IS DRIVING THE GROWTH OF THE DRUG DELIVERY TECHNOLOGY MARKET 133
8.5 DIABETES 134
8.5.1 EMERGENCE OF NEW TECHNOLOGIES IS SUPPORTING MARKET GROWTH 134
8.6 RESPIRATORY DISEASES 135
8.6.1 HIGH PREVALENCE OF ASTHMA & COPD TO DRIVE THE ADOPTION OF DRUG DELIVERY TECHNOLOGIES 135
8.7 CENTRAL NERVOUS SYSTEM DISORDERS 136
8.7.1 ORAL AND INJECTABLE DRUG DELIVERY SYSTEMS ARE WIDELY USED IN THE TREATMENT OF CNS DISORDERS 136
8.8 AUTOIMMUNE DISEASES 137
8.8.1 AUTOIMMUNE DISEASES SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 137
8.9 OTHER APPLICATIONS 138
8.9.1 OPHTHALMIC DISORDERS 138
8.9.2 ENDOCRINE DISORDERS 138
9 DRUG DELIVERY TECHNOLOGY MARKET, BY REGION 139
9.1 INTRODUCTION 140
9.2 NORTH AMERICA 140
9.2.1 US 152
9.2.1.1 Rising prevalence of chronic diseases and strong presence of key market players – Major factors driving market growth in the US 152
9.2.2 CANADA 153
9.2.2.1 Government support for research and the rising prevalence of chronic diseases are the major factors driving market growth in Canada 153
9.3 EUROPE 155
9.3.1 GERMANY 166
9.3.1.1 Growing focus of pharmaceutical companies on the development of various drug delivery products is expected to drive market growth in Germany 166
9.3.2 FRANCE 168
9.3.2.1 High insurance coverage coupled with the increasing prevalence of chronic diseases to drive market growth in France 168
9.3.3 UK 169
9.3.3.1 Increasing incidence and prevalence of chronic and infectious diseases to drive the demand for drug delivery technologies in the UK 169
9.3.4 REST OF EUROPE 171
9.4 ASIA PACIFIC 172
9.4.1 JAPAN 184
9.4.1.1 Favorable government initiatives and increasing geriatric population will drive market growth in Japan 184
9.4.2 CHINA 186
9.4.2.1 China had the largest diabetic population in the world in 2017 186
9.4.3 INDIA 187
9.4.3.1 Favorable initiatives and high disease incidence will drive market growth in India 187
9.4.4 REST OF ASIA PACIFIC 189
9.5 REST OF THE WORLD 190
10 COMPETITIVE LANDSCAPE 202
10.1 OVERVIEW 202
10.2 MARKET PLAYER RANKING, 2017 203
10.3 COMPETITIVE SCENARIO 204
10.4 COMPETITIVE LEADERSHIP MAPPING (2017) 206
10.4.1 VENDOR INCLUSION CRITERIA 206
10.4.2 VISIONARY LEADERS 206
10.4.3 INNOVATORS 206
10.4.4 DYNAMIC DIFFERENTIATORS 206
10.4.5 EMERGING COMPANIES 206
10.5 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017) 208
10.5.1 PROGRESSIVE COMPANIES 208
10.5.2 STARTING BLOCKS 208
10.5.3 RESPONSIVE COMPANIES 208
10.5.4 DYNAMIC COMPANIES 208
11 COMPANY PROFILE 210
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 JOHNSON & JOHNSON SERVICES, INC. 210
11.2 NOVARTIS AG 221
11.3 F. HOFFMANN-LA ROCHE LTD. 231
11.4 PFIZER, INC. 236
11.5 BAYER AG 249
11.6 ANTARES PHARMA, INC. 254
11.7 BECTON, DICKINSON AND COMPANY 256
11.8 GLAXOSMITHKLINE PLC 260
11.9 3M 267
11.10 MERCK & CO., INC. 269
11.11 SANOFI 276
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX 282
12.1 DISCUSSION GUIDE 282
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 286
12.3 AVAILABLE CUSTOMIZATIONS 288
12.4 RELATED REPORTS 288
12.5 AUTHOR DETAILS 289
【レポート販売概要】
■ タイトル：薬剤送達システムの世界市場予測（～2023年）■ 英文：Pharmaceutical Drug Delivery Market by Route (Oral (Tablet), Pulmonary (Nebulizer), Injectable, Ocular (Liquid), Topical (Solid), Implantable (Active), Transmucosal), Application (Cancer, Diabetes), Patient Care Setting (Hospital) - Global Forecast to 2023
■ 発行日：2019年3月5日
■ 調査会社：MarketsandMarkets
■ 商品コード：MD 3871
■ 調査対象地域：グローバル
- アジアの移動補助・運搬機器市場見通し（～2021）Asia-Pacific Mobility Aids and Transportation Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Mobility Aids and Transportation Equipment Market Outlook to 2021", provides key market data on the Asia-Pacific Mobility Aids and Transportation Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars) …
- 集光型太陽熱発電の新技術分析：Analyzing the Emerging Technology of Concentrated Solar PowerWith the advent of technology, a new generation of power plants has emerged. These power plants, with concentrating solar power systems, use the sun as a heat source. There are three main types of concentrating solar power systems: parabolic-trough, dish/engine, and power tower. Concentrating solar power systems utilizes concentrated solar radiation as a high temperature energy source to produce e …
- 産業用火災安全装置の世界市場：火災報知機、消火器About Fire Safety Fire safety is a combination of practices intended to check the destructive potential of fire. Fire prevention methods include those that aim to prevent the triggering of an unrestrained fire as well as those that are employed to limit the spread and consequences of a fire after it erupts. Industrial fire prevention specializes in protecting industrial manufacturing processes, pn …
- 銅市場：ウクライナThis report is a comprehensive research of woodworking industry in Ukraine. The first two chapters of the report feature the country profile by giving general information on Ukraine and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closi …
- Allengers Medical Systems Ltd.：市場シェア分析Allengers Medical Systems Ltd. Market Share Analysis Summary GlobalData’s new report, “Allengers Medical Systems Ltd. Market Share Analysis” provides in-depth information on Allengers Medical Systems Ltd.’s market position in the different medical equipment markets it operates in. The report provides Allengers Medical Systems Ltd. market share information in four key market categories – Lithotript …
- スーパーキャパシタの世界市場予測（～2022）：二重層、 疑似キャパシタ、ハイブリッドThe supercapacitor market is expected to grow at a CAGR of 20.7% and reach USD 2.18 Billion by 2022. A wide range of applications use supercapacitors as they provide a harmless, clean, and economical alternative energy solution to the industry. Also, the growing implementation of automobiles that uses electrical systems in the automotive industry is driving the growth of the overall supercapacitor …
- 禁煙治療薬の世界市場：ニコチン置換療法（NRT）、電子たばこAbout Smoking Cessation Products Smoking cessation products such as NRTs and e-cigarettes have proved useful in reducing the numbers of smokers worldwide. They can also be used to reduce smoking. A substantial number of smokers are now either quitting or trying to reduce smoking. This is because of increased awareness about the adverse effects of smoking; it is associated with a number of health h …
- 機関車エンジンサスペンションの世界市場About Locomotive Engine SuspensionLocomotive engine suspension: The locomotive suspension comprises the system of springs, suspension, and linkages that connect a vehicle to its wheels. It serves two purposes, namely improving vehicle's handling process and braking for good active safety and driving pleasure. The suspension keeps the passengers isolated from vibrations, noise, and road bumps. Tech …
- 導電性高分子の世界市場2017-2021ABSTRACTAbout Conductive Polymers Traditionally used polymers offer poor electrical conduction and act as excellent dielectrics and insulators. To overcome this, conductive powders such as silver, gold, and graphite are added in a polymer matrix. However, this technique results in deterioration of polymer properties and high cost. Since the inception of electrically conductive polymers, the scient …
- ケミカル石油増進回収法の世界市場：界面活性剤、水溶性高分子、高分子ゲル、生体高分子、アルカリ剤The EOR chemicals market is projected to register a CAGR of 7.8% between 2014 and 2019 to reach $150.35 million by 2019. North America held the largest share in 2013 with the U.S. being the leading country. In the less explored markets of Asia-Pacific and Oceania, high growth is expected while the highly developed North American region is predicted to show highest growth. Growth in the North Ameri …
- 液体塗布メンブレンの世界市場分析：製品別（セメント質、ビチューメン、ポリウレタン）、用途別（屋根、壁、建築物、埋立地およびトンネル）、エンドユーザー別（住宅、商業、工業、公共インフラ）、セグメント予測The global liquid applied membrane market is expected to reach USD 6.92 billion by 2022, according to a new report by Grand View Research, Inc. Technical advancements in liquid applied membrane, when compared to traditional systems, allow benefit in terms of cost reduction, better planning, and overall concrete protection. Liquid applied membranes have immense market potential on account of flexib …
- 脊椎用インプラント/デバイスの世界市場：胸部融合デバイス、腰部融合デバイス、頸部融合デバイス、脊椎用生物製剤、圧迫骨折治療デバイス、骨刺激装置The global spinal implants and spinal devices market is estimated to grow at a CAGR of 5.6% from 2015 to 2020. Although mature markets (such as North America and Europe) hold larger shares in the spinal implants and spinal devices market in 2015, the Asia-Pacific region is poised to grow at the highest CAGR of 8.2% in the next five years. Factors such as the presence of a large patient population, …
- 鼻閉塞(Nasal Obstruction)：世界の治験レビュー（2015年上半期版）Nasal Obstruction Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Nasal Obstruction Global Clinical Trials Review, H1, 2015" provides an overview of Nasal Obstruction clinical trials scenario. This report provides top line data relating to the clinical trials on Nasal Obstruction. Report includes an overview of trial numbers and their average enrollment in top …
- 血管肉腫(Angiosarcoma)：世界の治験レビュー（2015年上半期版）Angiosarcoma Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Angiosarcoma Global Clinical Trials Review, H1, 2015" provides data on the Angiosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Angiosarcoma. It includes an overview of the trial numbers and their recruitment status as per the sit …
- スマートカメラの世界市場2015-2019About Smart Camera A smart camera is a type of digital camera that has advanced connectivity features. Smart cameras can transfer photos wirelessly using Wi-Fi, NFC, and Bluetooth. They have the capability of interacting with smartphone and PC applications. These cameras can directly share and upload pictures and videos on various social media platforms and photo-sharing portals. A smart camera is …
